← Search

Data · dataset · 2023

Anti-RBD Ig, anti-RBD IgG, anti-S IgA and neutralizing activities in vaccinated individuals

Listed in Teesside University Research Data Repository

This is a cross-sectional study in which leftover sera samples from participants vaccinating with either heterologous inactivated CoronaVac followed by BNT162b2 vaccine (n=76), two-dose CoronaVac (n=170), or two-dose BNT162b2 regimen (n=19).

Description

The homologous group received vaccine at 21-28 days apart. The heterologous CoronaVac/BNT162b2 received vaccine at varying intervals according to the availability of the second dose vaccine.

Blood samples were collected between 21and 35 days after the second dose vaccination. Serological testing against SARS-CoV-2 was performed on serum samples.

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 6 field assertions
SourceKeyLast seenRaw
Teesside University Research Data Repositoryoai:data.mendeley.com/v6r77mj4s9.19 h agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
descriptionsource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/description
licensesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/rights
publication_datesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0
titlesource · researchdata tees ac ukconnector:researchdata_tees_ac_uk@1.0.0/metadata/dc/title